What do you see as the way forward for the company if the conciliation process doesn't yield any favorable result or clear path toward approval after P3 results?
Would focus switch to other markets? It would seem like the market opportunity of Australia compared to Europe would be a fraction anyway.
Also, this may be in existing company documents but not that I could see with some research but is the US market something that will be of focus in 2024?
- Forums
- ASX - By Stock
- FRE
- Ann: Firebrick Update on AAT Schedule
FRE
firebrick pharma limited
Add to My Watchlist
3.33%
!
6.2¢

Ann: Firebrick Update on AAT Schedule, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.2¢ |
Change
0.002(3.33%) |
Mkt cap ! $13.92M |
Open | High | Low | Value | Volume |
6.5¢ | 6.6¢ | 6.2¢ | $2.572K | 40.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 1716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 0.061 |
3 | 217685 | 0.060 |
3 | 50000 | 0.059 |
1 | 80000 | 0.058 |
1 | 100000 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 1716 | 1 |
0.080 | 47101 | 2 |
0.088 | 5758 | 2 |
0.090 | 100 | 1 |
0.091 | 948112 | 2 |
Last trade - 13.19pm 27/06/2025 (20 minute delay) ? |
Featured News
FRE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online